Brigit Biofarmaka Teknologi Tbk. vs Transkon Jaya Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Transkon Jaya Tbk. trades at Rp128 (market cap 196.33B, 531.6K 24h volume). The key difference: Transkon Jaya Tbk. is the larger of the two by market cap, and Transkon Jaya Tbk. is more actively traded (531.6K versus 324K). Which is the better fit depends on your goals.
| OBAT | TRJA | |
|---|---|---|
Market Cap | 166.01B | 196.33B |
Volume | 324K | 531.6K |
Lot | 3.24K | 5.32K |
Turnover | 77.68M | 67.73M |
Average Price | 239.75 | 127.4 |
Value | 77.68M | 67.73M |
Indicative Equilibrium Price | 240 | 128 |
Indicative Equilibrium Volume | 1 | 5 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Transkon Jaya Tbk (the Company) was established based on the Notarial Deed of Adi Gunawan, SH., No. 27 dated January 4, 2002. The Company started its commercial operations in July2002. The Companys immediate parent company is PT Damai Investa Sukses, incorporated and domiciledin Indonesia.
Read more on TRJA →